Function and regulation of the transcription factors of the Myc/Max/Mad network

Gene

Volumn 277, Issue 1-2, 2001, Pages 1-14

  Lüscher, Bernhard ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cell cycle; Chromatin; Differentiation; Oncogene; Signaling; Transformation

Indexed keywords

ADENOSINE TRIPHOSPHATASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; MAX PROTEIN; MYC PROTEIN; PROTEIN MAD; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHROMATIN; DEREGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; HUMAN; MODULATION; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; REPRESSOR GENE; REVIEW; STIMULATION; TRANSCRIPTION REGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL CYCLE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0035904463     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(01)00697-7     Document Type: Review

References (162)

1. What does 'chromatin remodeling' mean?
2. Oncogene co-operation in leukaemogenesis
3. Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks
4. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines
5. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
6. Integrating Myc and TGF-beta signalling in cell-cycle control
7. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
8. Oncogenic activity of the c-Myc protein requires dimerization with Max
9. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max
10. Function of the c-Myc oncoprotein in chromatin remodeling and transcription
11. Myc inhibits CCAAT/enhancer-binding protein alpha-gene expression in HIB-1B hibernoma cells through interactions with the core promoter region
12. The aminoterminal phosphorylation sites are frequenyly mutated in Burkitt Lymphomas but not in mouse plasmacytomas
13. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation
14. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
15. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased
16. Myc but not Fos rescue of PDGF signalling block caused by kinase- inactive Src
17. The retinoblastoma protein pathway in cell cycle control and cancer
18. The Max network gone mad
19. Tumorigenesis in transgenic mice: Identification and characterization of synergizing oncogenes
20. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphomas and mouse plasmacytomas
21. Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas
22. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors
23. MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network
24. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc
25. Myc and Max function as a nucleoprotein complex
26. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling
27. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases
28. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
29. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter
30. Identification of target genes of oncogenic transcription factors
31. WBSCR14, a gene mapping to the Williams-Beuren syndrome deleted region, is a new member of the Mlx transcription factor network
32. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene
33. Ubiquitylation and destruction of endogenous c-mycS by the proteasome: Are myc boxes dispensable?
34. c-Myc interacts with INI1/hSNF5 and requires the SWI/SNF complex for activation function
35. Signaling to chromatin through histone modifications
36. Regulation of c-myc expression by PDGF through Rho GTPases
37. Myc-mediated transformation: The repression connection
38. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest
39. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
40. c-Myc target genes involved in cell growth, apoptosis, and metabolism
41. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice
42. Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression
43. The Myc protein activates transcription of the a-prothymosin gene
44. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle
45. Induction of apoptosis in fibroblasts by c-myc protein
46. The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights
47. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter
48. Transient excess of MYC activity can elicit genomic instability and tumorigenesis
49. Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts
50. Myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome
51. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation
52. Binding of c-Myc to its target sites in chromatin mediates mitogen-induced acetylation of histone H4 and gene activation
53. Chromatin remodeling enzymes: Who's on first?
54. Cdc25 cell cycle phosphatase as a target of c-myc
55. Contacts in context: Promoter specificity and macromolecular interactions in transcription
56. Myc target genes
57. The Myc/Max/Mad network and the transcriptional control of cell behavior
58. The ATM-related cofactor Tra1 is a component of the purified SAGA complex
59. c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells
60. Identification of c-myc responsive genes using rat cDNA microarray
61. The Rb/E2F pathway: Expanding roles and emerging paradigms
62. d, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein
63. Histone deacetylase activity is required for full transcriptional repression by mSin3A
64. Proteins of the Myc network: Essential regulators of cell growth and differentiation
65. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential
66. Identification of CDK4 as a target of c-MYC
67. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain
68. Mnt: A novel Max-interacting protein and Myc antagonist
69. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif
70. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis
71. c-Myc enhances protein synthesis and cell size during B lymphocyte development
72. Mechanism for the transcriptional repression by c-Myc on PDGFb-receptor
73. Differential modulation of cyclin gene expression by Myc
74. Drosophila Myc regulates cellular growth during development
75. Eukaryotic transcription: An interlaced network of transcription factors and chromatin-modifying machines
76. Transcriptional control: Calling in histone deacetylase
77. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity
78. Sin meets NuRD and other tails of repression
79. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome
80. Targeting of the transcription factor Max during apoptosis: Phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid in position P1
81. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression
82. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
83. A link between c-Myc-mediated transcriptional repression and neoplastic transformation
84. Myc represses transcription of the growth arrest gene gas1
85. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II
86. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis
87. Proteins encoded by the c-myc oncogene: Analysis of the c-myc protein degradation
88. New light on Myc and Myb. Part I
89. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: Function and regulation
90. Myc oncoproteins are phosphorylated by casein kinase II
91. The c-myc protein represses the lambda 5 and TdT initiators
92. Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression
93. myc function and regulation
94. Differential regulation of the c-MYC P1 and P2 promoters in the absence of functional tumor suppressors: Implications for mechanisms of deregulated MYC transcription
95. Myc represses the growth arrest gene gadd45
96. TGFbeta signaling in growth control, cancer, and heritable disorders
97. The novel ATM-related protein TRRAP is an essential cofactor for the c- Myc and E2F oncoproteins
98. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
99. Mlx, a new Max-like bHLHZip family member: The center stage of a novel transcription factors regulatory pathway?
100. Analysis of C-MYC function in normal cells via conditional gene- targeted mutation
101. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer
102. The mammalian SWI/SNF complex and the control of cell growth
103. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes
104. Making decisions through Myc
105. MYC oncogenes and human neoplastic disease
106. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
107. Gene-target recognition among members of the myc superfamily and implications for oncogenesis
108. Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression
109. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
110. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis
111. Action of Myc in vivo - Proliferation and apoptosis
112. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes
113. Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1)
114. Promoter targeting and chromatin remodeling by the SWI/SNF complex
115. An alternative pathway for gene regulation by Myc
116. Repression of cyclin D1: A novel function of Myc
117. Mechanisms of apoptosis by c-Myc
118. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation
119. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo
120. Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1
121. Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis
122. Control of the G1/S transition
123. Direct role for Myc in transcription initiation mediated by interactions with TFII-I
124. Tra1p is a component of the yeast Ada.Spt transcriptional regulatory complexes
125. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc
126. Repression by the Mad(Mxi1)-Sin3 complex
127. Role of Mxi1 in aging organ systems and the regulation of normal and neoplastic growth
128. Control of cell growth by c-Myc in the absence of cell division
129. The transcriptional program of a human B cell line in response to Myc
130. Ras enhances Myc protein stability
131. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
132. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
133. Signal transduction within the nucleus by mitogen-activated protein kinase
134. Cell cycle regulation of the c-Myc transcriptional activation domain
135. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro
136. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2
137. Essential role for Max in early embryonic growth and development
138. CDK inhibitors: Positive and negative regulators of G1-phase progression
139. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc
140. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity
141. Control of c-myc regulation in normal and neoplastic cells
142. Repression of p15INK4b expression by Myc through association with Miz-1
143. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo do develop
144. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes
145. The language of covalent histone modifications
146. Chromatin structure and RNA polymerase II connection: Implications for transcription
147. T-targets: Clues to understanding the functions of T-box proteins
148. Transcriptional activation: Risky business
149. c-Myc-associated genomic instability of the dihydrofolate reductase locus in vivo
150. Transcriptional regulation: Kamikaze activators
151. The many roles of c-Myc in apoptosis
152. The ubiquitin system
153. The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily
154. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
155. Cell-cycle inhibitors: Three families united by a common cause
156. Nuclear visions: Functional flexibility from structural instability
157. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc
158. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC
159. Transactivation-defective c-mycS retains the ability to regulate proliferation and apoptosis
160. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells
161. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc
162. Clustered mutations in the second exon of the myc gene in sporadic Burkitt's lymphomas